ieramilimab (LAG525) - Novartis
IMP761 - Immutep
ImmuFact (eftilagimod alpha) - Immutep
https://www.globenewswire.com/news-release/2024/10/29/2970729/0/en/Immutep-Quarterly-Activities-Report-Q1-FY25.html
 
Oct 29, 2024
 
Next